Posted on 10/28/19
Oncology Start-Up Nuvation Bio Closes $275 Million Series A Financing Led by Omega Funds
Nuvation Bio, Inc., a stealth biotechnology company developing proprietary therapies focused on oncology, announces the closing of $275 million in an oversubscribed Series A financing.
Posted on 10/28/19
Athene and Apollo Announce Transaction to Strengthen Strategic Relationship
PEMBROKE, Bermuda & NEW YORK--(BUSINESS WIRE)--Athene Holding Ltd. (NYSE: ATH), a leading retirement services company, and Apollo Global Management, Inc. (NYSE: APO), a leading global alternative . . .
Posted on 10/28/19
BASF and Greentown Labs Announce Startup Finalists in the Circularity Challenge
BASF, one of the world's leading chemical companies, and Greentown Labs, the largest cleantech incubator in North America, have selected five startups for their Circularity Challenge, . . .
Posted on 10/28/19
Better Buy: Pfizer vs. Merck
If you're looking for great dividend stocks, big pharma should be on your list. But some huge drugmakers can also provide plenty of growth over the . . .
Posted on 10/28/19
Better Buy: Vertex Pharmaceuticals vs. Incyte
If you picked which stock to buy based solely on year-to-date performance, Incyte (NASDAQ:INCY) would get the nod over Vertex Pharmaceuticals (NASDAQ:VRTX). Both biotech stocks have . . .
Posted on 10/25/19
iBio Prices $5M Public Offering
NEW YORK, Oct. 25, 2019 (GLOBE NEWSWIRE) -- IBIO, INC. (NYSE AMERICAN: IBIO) announced the pricing of an underwritten public offering with expected total gross proceeds of . . .
Posted on 10/24/19
Tri-State Hospital Group Partners to Improve Healthcare Quality, Patient Safety
Three hospital associations in New Jersey, Ohio and Pennsylvania today announced the creation of Q3 Health Innovation Partners (Q3HIP), a new joint venture to improve health . . .
Posted on 10/24/19
Advaxis Announces Business and Pipeline Update
PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced the following updates to . . .
Posted on 10/24/19
Soligenix Receives US Patent for Improved Production of Synthetic Hypericin Composition
Soligenix, Inc. (Nasdaq: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced . . .
Posted on 10/24/19
Athenex Provides An Update to Shareholders
BUFFALO, N.Y., Oct. 24, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies . . .
Posted on 10/24/19
Integra LifeSciences Reports Third Quarter 2019 Financial Results
PLAINSBORO, N.J., Oct. 24, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the . . .
Posted on 10/24/19
Acorda Therapeutics Implements Corporate Restructuring
ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced a corporate restructuring to reduce costs and focus its resources on the launch of INBRIJA. As part . . .
Posted on 10/23/19
BioAegis Therapeutics Named New Jersey’s Most Valuable Venture-Backed Company Led by a Woman
MORRISTOWN, N.J., Oct. 22, 2019 (GLOBE NEWSWIRE) -- BioAegis Therapeutics was recently recognized by PitchBook as the most valuable venture-backed company in New Jersey led by . . .
Posted on 10/23/19
Colangelo Adds Vireo Health to Client Roster
Medical Cannabis Company Taps Colangelo’s Occasion-Based Approach to Launch First Recreational Brand. Colangelo, the marketing agency focused on Brand Attachment, announced today that it has been . . .
Posted on 10/23/19
Progenics To Be Acquired By Lantheus Holdings: Deciding To Buy, Sell, Or Hold
On October 2nd, Lantheus Holdings (LNTH) Progenics Pharmaceuticals (PGNX), announced an agreement for Lantheus to acquire Progenics in an all-stock transaction.
Posted on 10/22/19
Onegevity Health Acquires Global Licensing Rights to Mount Sinai's Lab100
Onegevity Health, LLC, a New York City-based health technology company focused on biometric data, artificial intelligence and personalized wellness, has acquired the global licensing rights to . . .
Posted on 10/22/19
Quest Diagnostics Reports Third Quarter 2019 Financial Results
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the third quarter ended September 30, 2019."We had . . .
Posted on 10/22/19
Boston Scientific Announces Cash Tender Offer for Up To $1.0 Billion of Its Outstanding Debt Securities
Boston Scientific Corporation (NYSE:BSX) today announced the commencement of a cash tender offer for up to $1.0 billion aggregate principal amount of the outstanding senior notes . . .
Posted on 10/22/19
Why I Added More Johnson & Johnson During Friday's Overreactive Dip
SummaryOn Friday, (JNJ) closed -6.22% after they voluntarily recalled a single lot of Baby Powder after trace levels of asbestos were found in tests.I explain why . . .
Posted on 10/22/19
IPO Update: Oyster Point Pharma Readies $85 Million IPO
SummaryOyster Point Pharma has filed proposed terms for its U.S. IPO.The firm is developing treatments for various eye conditions.OYST has a potential mid-2020 catalyst when it . . .
Posted on 10/22/19
Johnson & Johnson: Yield Still Not Worth The Legal Risk
SummaryJ&J reported limited Q3 growth despite the initial market excitement over the results.Analysts continue to forecast minimal EPS growth for a stock trading at 15x '19 . . .
Posted on 10/22/19
Pfizer: Avoid This High Yield
SummaryPfizer trades at yearly lows after a 2019 EPS cut and the announced business combination with Mylan.The stock spent far too much on stock buybacks in . . .
Posted on 10/21/19
HealthEC, LabCorp, and The New Jersey Primary Care Association Announce Strategic Collaboration
BURLINGTON, N.C. & EDISON, N.J. & HAMILTON, N.J.--(BUSINESS WIRE)--LabCorp® (NYSE:LH), a leading global life sciences company, HealthEC, LLC, a 2019 Best in KLAS provider of population . . .
Posted on 10/21/19
Why Johnson & Johnson Stock Sank Today
What happenedShares of Johnson & Johnson (NYSE:JNJ) were sinking by 5.9% as of 3:31 p.m. EDT on Friday after the healthcare giant announced a recall of . . .
Posted on 10/21/19
Better Buy: Geron vs. Celgene
For the most part, biotech stocks aren't having a great year with only a little over two months left in 2019. The top biotech-focused exchange-traded funds . . .

